Cosmetic, Prescription, and Research Peptides: Key Differences

A peptide serum, a peptide prescription drug, a collagen peptide powder and a "research peptide" can sound like four versions of one thing. In the United States they belong to different legal categories, with different rules about approval, labeling and claims. This guide explains each category using the FDA's own descriptions, as checked on the date shown on this page.

Intended use decides the category

US law defines cosmetics and drugs by what a product is meant to do. Under the Federal Food, Drug, and Cosmetic Act, cosmetics are products for uses such as cleansing or beautifying. Drugs include products meant to diagnose, cure, mitigate, treat or prevent disease, and products meant to affect the structure or function of the body ^{Source [1]}.

The FDA says intended use can be established in several ways, including claims on labels, in advertising and online; why consumers buy the product; and ingredients with a well-known therapeutic use. A product that claims to restore hair growth, for example, can be a drug even if it is sold as a cosmetic. A product can also be both, like a dandruff shampoo, and must then meet both sets of rules. The marketing term "cosmeceutical" has no meaning under the law ^{Source [1]}.

Cosmetic peptides

When a peptide serum or cream is sold as a cosmetic, these rules apply. Cosmetic products and ingredients, other than color additives, do not need FDA approval before they go on sale. Companies are legally responsible for making sure their products are safe, but the law does not require any specific safety test ^{Source [2]}.

The Modernization of Cosmetics Regulation Act of 2022 (MoCRA) added new duties for the companies responsible for cosmetics. Facilities must register with the FDA and renew every two years, each marketed product must be listed with its ingredients, serious adverse events must be reported within 15 business days, and companies must keep records supporting the safety of their products. In defined circumstances the FDA can now order a recall ^{Source [3]}.

On the label, ingredients appear in descending order of predominance, except that ingredients at one percent or less and color additives may be listed without regard to that order ^{Source [4]}. The regulations do not require the label to state ingredient concentrations ^{Source [5]}. In practice, a serum can name a peptide without telling you how much it contains.

What this means for evidence: nobody at the FDA reviewed whether a cosmetic peptide works before the product was sold. Studies cited for a claim may have been run by the maker or an ingredient supplier, or may have tested the ingredient in a different formula. Our guide to copper peptides in skincare shows how to read that kind of evidence.

Prescription peptide medicines

Drugs generally need FDA approval, or must follow an over-the-counter monograph, before they are sold ^{Source [1]}. For a new drug, the company runs laboratory and animal studies, then human trials, and sends the evidence to the FDA's Center for Drug Evaluation and Research. Reviewers examine the data and the proposed labeling, and approve the drug if its benefits outweigh its known and potential risks for the people it is meant for ^{Source [6]}.

Semaglutide is an example of a peptide medicine. Ozempic, one product containing it, is a prescription injection given under the skin, marketed under a New Drug Application and first approved in 2017 ^{Source [7]}. Its approval covers that product as labeled: its form, its route and the uses listed in its prescribing information.

Size can change the pathway. Since March 23, 2020, a molecule with a specific, defined sequence of more than 40 amino acids counts as a protein under FDA rules, and protein products such as insulin fall under the legal definition of a biological product instead of the drug-approval pathway ^{Source [8]}.

Compounded versions

A pharmacy can sometimes prepare a version of a drug for a patient, for example without a dye the patient is allergic to. Compounded drugs are not FDA-approved, and the FDA does not verify their safety, effectiveness or quality before they are sold. Licensed pharmacists and physicians compound under section 503A, and state boards of pharmacy generally have primary responsibility for day-to-day oversight. Outsourcing facilities registered with the FDA compound under section 503B and must meet current good manufacturing practice. The FDA says compounded drugs should be used only when an approved drug cannot meet a patient's needs ^{Source [9]}. Our guide to approved, compounded and unapproved drugs goes further.

Dietary supplement peptides

Collagen peptide powders and other swallowed products sold as supplements follow a separate framework. The Dietary Supplement Health and Education Act of 1994 defines a supplement as a product taken by mouth that contains a dietary ingredient, such as a vitamin, mineral, botanical or amino acid, and is labeled as a dietary supplement. It must be swallowed: the FDA gives topical and inhaled products as examples that do not qualify, and an injected product does not fit the definition either ^{Source [10]}.

The FDA does not have the authority to approve supplements before they are marketed. Manufacturers and distributors are responsible for safety and labeling, including a Supplement Facts panel. An ingredient that was not sold in the United States before October 15, 1994 generally requires a notification to the FDA at least 75 days before it is marketed. Supplements may make structure or function claims, which the company must be able to substantiate, but the label must then say the statement has not been evaluated by the FDA and that the product is not intended to diagnose, treat, cure or prevent any disease. Manufacturers must also follow good manufacturing practices meant to ensure identity, purity, strength and composition ^{Source [10]}.

"Research use only" peptides

Some sellers offer peptides labeled "for research purposes" or "not for human consumption." That label describes how the seller says the material should be used: in laboratory research, not by people. It is not an FDA approval, and it does not turn the material into a cosmetic, a supplement or an approved drug.

The label also does not settle what a product is. As with cosmetics and drugs, the FDA looks at intended use, including how a product is promoted ^{Source [1]}. The agency has warned companies that sold unapproved GLP-1 drugs, falsely labeled for research or as not for human consumption, directly to consumers with dosing instructions, and it urges consumers not to buy them ^{Source [11]}.

On this site, the research category covers study literature and supplier documentation. It never includes human-use guidance. Two guides explain what to check: What a Certificate of Analysis Can and Cannot Tell You and Why Product Availability Is Not Regulatory Approval.

The four categories side by side

• Cosmetic: no FDA approval before sale (color additives aside); used on the skin; ingredient list in order of predominance, usually without percentages; claims limited to appearance, since treatment claims make a product a drug.
• Prescription drug: FDA approval based on the company's evidence, or compounding under separate rules without approval; form and route set by the approval; prescribing information lists the approved uses.
• Dietary supplement: no FDA approval before sale; swallowed; Supplement Facts panel; structure or function claims only, with the FDA disclaimer.
• Research material: no FDA review; not intended for people; a seller's label is not evidence of quality or suitability.

Knowing the category does not tell you whether a product works. It tells you which questions to ask next, and which evidence is relevant. We do not give dosing guidance or personal medical advice.